SG10201912572VA - Treatment of diabetic peripheral neuropathy using placental cells - Google Patents

Treatment of diabetic peripheral neuropathy using placental cells

Info

Publication number
SG10201912572VA
SG10201912572VA SG10201912572VA SG10201912572VA SG10201912572VA SG 10201912572V A SG10201912572V A SG 10201912572VA SG 10201912572V A SG10201912572V A SG 10201912572VA SG 10201912572V A SG10201912572V A SG 10201912572VA SG 10201912572V A SG10201912572V A SG 10201912572VA
Authority
SG
Singapore
Prior art keywords
treatment
peripheral neuropathy
placental cells
diabetic peripheral
diabetic
Prior art date
Application number
SG10201912572VA
Other languages
English (en)
Inventor
Steven Fischkoff
Denesh Chitkara
Original Assignee
Celularity Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Celularity Inc filed Critical Celularity Inc
Publication of SG10201912572VA publication Critical patent/SG10201912572VA/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48Reproductive organs
    • A61K35/50Placenta; Placental stem cells; Amniotic fluid; Amnion; Amniotic stem cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Reproductive Health (AREA)
  • Dermatology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
SG10201912572VA 2015-09-15 2016-09-14 Treatment of diabetic peripheral neuropathy using placental cells SG10201912572VA (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201562218885P 2015-09-15 2015-09-15

Publications (1)

Publication Number Publication Date
SG10201912572VA true SG10201912572VA (en) 2020-02-27

Family

ID=58289824

Family Applications (1)

Application Number Title Priority Date Filing Date
SG10201912572VA SG10201912572VA (en) 2015-09-15 2016-09-14 Treatment of diabetic peripheral neuropathy using placental cells

Country Status (17)

Country Link
US (2) US20180264048A1 (https=)
EP (2) EP3349771A4 (https=)
JP (3) JP2018529683A (https=)
KR (1) KR20180051631A (https=)
CN (1) CN108367028A (https=)
AU (1) AU2016323120A1 (https=)
BR (1) BR112018005014B1 (https=)
CA (1) CA2998759A1 (https=)
CO (1) CO2018003759A2 (https=)
EA (1) EA201890720A1 (https=)
IL (2) IL281185B2 (https=)
MX (1) MX2018003275A (https=)
MY (1) MY203748A (https=)
NZ (1) NZ740663A (https=)
SG (1) SG10201912572VA (https=)
WO (1) WO2017048741A1 (https=)
ZA (1) ZA201801708B (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN118284725A (zh) 2021-11-10 2024-07-02 三菱化学株式会社 碳纤维、碳纤维束和碳纤维束的制造方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5190556A (en) 1991-03-19 1993-03-02 O.B. Tech, Inc. Cord cutter sampler
US5372581A (en) 1993-07-21 1994-12-13 Minneapolis Children's Services Corporation Method and apparatus for placental blood collection
US6384105B1 (en) 1999-04-16 2002-05-07 William Marsh Rice University Poly(Propylene Fumarate) cross linked with Poly(Ethylene Glycol)
US6355699B1 (en) 1999-06-30 2002-03-12 Ethicon, Inc. Process for manufacturing biomedical foams
DK1349918T3 (da) 2000-12-06 2014-11-10 Anthrogenesis Corp Fremgangsmåde til indsamling af stamceller fra moderkagen
US7311905B2 (en) 2002-02-13 2007-12-25 Anthrogenesis Corporation Embryonic-like stem cells derived from post-partum mammalian placenta, and uses and methods of treatment using said cells
EP3246396B1 (en) 2001-02-14 2020-01-29 Celularity, Inc. Renovation and repopulation of decellularized tissues and cadaveric organs by stem cells
EP2316919B1 (en) 2001-02-14 2015-10-07 Anthrogenesis Corporation Post-partum mammalian placenta, its use and placental stem cells therefrom
US20030187515A1 (en) 2002-03-26 2003-10-02 Hariri Robert J. Collagen biofabric and methods of preparing and using the collagen biofabric
US20040161419A1 (en) * 2002-04-19 2004-08-19 Strom Stephen C. Placental stem cells and uses thereof
US7255729B2 (en) 2003-05-30 2007-08-14 Noritake Co., Limited Porous cylindrical-body module, structure for supporting porous cylindrical bodies, and method for fastening a supporting member
US7147626B2 (en) 2004-09-23 2006-12-12 Celgene Corporation Cord blood and placenta collection kit
PT2471904T (pt) 2005-12-29 2019-02-25 Celularity Inc População de células estaminais placentárias
CA2633980A1 (en) 2005-12-29 2007-07-12 Anthrogenesis Corporation Improved composition for collecting and preserving placental stem cells and methods of using the composition
US20090018151A1 (en) * 2007-02-23 2009-01-15 Ezekiel Fink Topical Treatment of Peripheral diabetic complications
LT2556145T (lt) * 2010-04-07 2016-11-10 Anthrogenesis Corporation Angiogenezė naudojant placentos kamienines ląsteles
JP6104896B2 (ja) * 2011-06-01 2017-03-29 アントフロゲネシス コーポレーション 胎盤幹細胞を使用する疼痛の治療

Also Published As

Publication number Publication date
EP3957315A1 (en) 2022-02-23
IL258048A (en) 2018-05-31
CA2998759A1 (en) 2017-03-23
IL281185B1 (en) 2024-01-01
NZ740663A (en) 2022-12-23
JP2021183635A (ja) 2021-12-02
IL281185B2 (en) 2024-05-01
EA201890720A1 (ru) 2018-09-28
BR112018005014B1 (pt) 2022-03-22
US20220072063A1 (en) 2022-03-10
JP2018529683A (ja) 2018-10-11
JP2023171769A (ja) 2023-12-05
MX2018003275A (es) 2018-05-16
EP3349771A1 (en) 2018-07-25
KR20180051631A (ko) 2018-05-16
WO2017048741A1 (en) 2017-03-23
EP3349771A4 (en) 2019-04-24
IL281185A (en) 2021-04-29
CN108367028A (zh) 2018-08-03
CO2018003759A2 (es) 2018-12-14
BR112018005014A2 (https=) 2018-10-02
ZA201801708B (en) 2019-01-30
US20180264048A1 (en) 2018-09-20
AU2016323120A1 (en) 2018-04-12
MY203748A (en) 2024-07-17

Similar Documents

Publication Publication Date Title
IL253795B (en) Methods for treating cancer using activated t cells
IL253803A0 (en) A preparation for the treatment of hypothyroidism
EP3261713A4 (en) Blood pump for treatment of bradycardia
EP3145875A4 (en) Electrochemical treatment methods
EP3116484A4 (en) Treating diseases using nitric oxide releasing solutions
EP3297653A4 (en) Treatment of post-bariatric hypoglycemia with glp-1 antagonists
IL255834A (en) Electrochemical biosensor
IL292054A (en) Compositions for treatment of abnormal cell growth
IL259486A (en) Agents for the treatment of diseases associated with undesired cell proliferation
EP3228302A4 (en) Hair deformation treatment agent
EP3228303A4 (en) Hair deformation treatment agent
EP3228300A4 (en) Hair deformation treatment agent
HUE052584T2 (hu) Pluripotens õssejt diabéteszes bõrfekély kezelésére
GB201519450D0 (en) Novel treatment
ZA201704521B (en) Treatment of ocular conditions using progenitor cells
GB201522223D0 (en) Therapeutic T cells
GB201519331D0 (en) Treatment paradigm
ZA201608406B (en) Enzyme treatment composition
IL281185A (en) Treatment of diabetic peripheral neuropathy using placental cells
GB201517329D0 (en) Diabetes gene therapy
IL267231A (en) Methods of treating diseases associated with ilc2 cells
EP3271017A4 (en) Treatment of skin conditions
GB201601456D0 (en) Improvements relating to retinal treatment
GB201511752D0 (en) Treatment of post-consumer bales
EP3197467A4 (en) Treatment of diabetic foot ulcer using placental stem cells